DekaBank Deutsche Girozentrale’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-21,500
| Closed | -$468K | – | 1246 |
|
|
2017
Q4 | $468K | Hold |
21,500
| – | – | ﹤0.01% | 834 |
|
|
2017
Q3 | $468K | Hold |
21,500
| – | – | ﹤0.01% | 840 |
|
|
2017
Q2 | $467K | Hold |
21,500
| – | – | ﹤0.01% | 844 |
|
|
2017
Q1 | $294K | Sell |
21,500
-1,800
| -8% | -$29.5K | ﹤0.01% | 812 |
|
|
2016
Q4 | $437K | Buy |
23,300
+1,800
| +8% | +$30.6K | ﹤0.01% | 682 |
|
|
2016
Q3 | $350K | Hold |
21,500
| – | – | ﹤0.01% | 736 |
|
|
2016
Q2 | $284K | Buy |
21,500
+6,200
| +41% | +$90.4K | ﹤0.01% | 797 |
|
|
2016
Q1 | $229K | Sell |
15,300
-2,700
| -15% | -$42.3K | ﹤0.01% | 825 |
|
|
2015
Q4 | $369K | Buy |
18,000
+1,300
| +8% | +$24.7K | ﹤0.01% | 750 |
|
|
2015
Q3 | $291K | Buy |
16,700
+800
| +5% | +$16.3K | ﹤0.01% | 791 |
|
|
2015
Q2 | $321K | Buy |
15,900
+600
| +4% | +$11.6K | ﹤0.01% | 792 |
|
|
2015
Q1 | $269K | Sell |
15,300
-2,100
| -12% | -$35.8K | ﹤0.01% | 836 |
|
|
2014
Q4 | $276K | Sell |
17,400
-1,600
| -8% | -$29.4K | ﹤0.01% | 809 |
|
|
2014
Q3 | $419K | Buy |
19,000
+400
| +2% | +$8.19K | 0.01% | 695 |
|
|
2014
Q2 | $374K | Sell |
18,600
-700
| -4% | -$11.9K | 0.01% | 663 |
|
|
2014
Q1 | $359K | Buy |
19,300
+1,500
| +8% | +$20.7K | 0.01% | 635 |
|
|
2013
Q4 | $182K | Buy |
17,800
+500
| +3% | +$6.04K | ﹤0.01% | 673 |
|
|
2013
Q3 | $223K | Buy |
17,300
+800
| +5% | +$9.84K | ﹤0.01% | 651 |
|
|
2013
Q2 | $202K | Buy |
+16,500
| New | +$179K | ﹤0.01% | 534 |
|
DekaBank Deutsche Girozentrale's AMRI Position: Q1 2018 in Review
DekaBank Deutsche Girozentrale sold out of Albany Molecular Research Inc (AMRI) in Q1 2018, closing a stake of 21,500 shares — an estimated $468K sold.
DekaBank Deutsche Girozentrale first reported a position in AMRI in Q2 2013 and held it in 19 quarters. The position peaked at $468K in Q4 2017. 0 funds tracked by Wall St. Rank hold AMRI as of Q1 2018.
- DekaBank Deutsche Girozentrale reported no remaining Albany Molecular Research Inc position as of Q1 2018 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 21,500 Albany Molecular Research Inc shares in Q1 2018, an estimated $468K.
- DekaBank Deutsche Girozentrale first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 19 quarters.
- DekaBank Deutsche Girozentrale's Albany Molecular Research Inc position peaked at $468K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2018.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2018, filed 3 May 2018.